OConnell Daniel Joseph - Insider Non-Derivative Transactions at Acumen Pharmaceuticals, Inc. (ABOS) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 19, 2024, OConnell Daniel Joseph's relationship to Acumen Pharmaceuticals, Inc. (ABOS) is Director,Officer (President and CEO), and currently has 502,485 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ABOS insiders.
Data Source: SEC.
OConnell Daniel Joseph - Insider Non-Derivative Transactions of ABOS Common Stock
OConnell Daniel Joseph - Insider Non-Derivative Transactions at ABOS
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 20, 2024 | Sell -- (Common Stock) | 15200 | 3.47 | 502485 |
| Jan 3, 2024 | Acquisition -- (Common Stock) | 401000 | 0 | 517685 |
| Jan 18, 2023 | Acquisition -- (Common Stock) | 114000 | 0 | 116685 |